5/15 The 200μg dose showed similar efficacy (6.0-point reduction) but with more side effects, while 25μg and 50μg doses showed no significant benefit.
This established 100μg as the optimal therapeutic dose for Phase 3 trials.
#OptimalDose #DoseResponse
2
0
1
0